Clinical Trials · NCT04648969
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Stephanie B. Seminara, MD
- Enrollment
- 18
- Start date
- May 2019
- Locations
- 1 site, United States
- Primary endpoint
- Average Change in Luteinizing Hormone (LH) Pulse Amplitude in Response to Kisspeptin